0
Erlotinib hydrochloride, is a medication that inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase.

Erlotinib Hydrochloride

SNC00615
Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined as a first-line treatment for locally advanced and metastatic pancreatic cancer.
Quantity:
Contact Now
add to cart

Product Details

 

Erlotinib hydrochloride, is a medication that inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase. Here are some of its uses based on the available information:

  1. Metastatic Non-Small Cell Lung Cancer (NSCLC): Erlotinib is used for the treatment of metastatic NSCLC that has tumors showing epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.

  2. Locally Advanced or Metastatic NSCLC: Erlotinib hydrochloride is used as a single agent for patients with locally advanced or metastatic NSCLC who have received at least one prior chemotherapy regimen.

  3. Maintenance Treatment: Erlotinib can be used as maintenance therapy for patients with locally advanced or metastatic NSCLC who have responded to four cycles of first-line, platinum-based chemotherapy.

  4. Pancreatic Cancer: Erlotinib hydrochloride is also used in the treatment of pancreatic cancer, particularly in cases that have spread or are advanced.

  5. EGFR Mutation-Positive NSCLC: Erlotinib is used as a first-line treatment for patients with EGFR mutation-positive NSCLC.

  6. Combination Therapy: Although not recommended for first-line treatment in combination with platinum-based chemotherapy for NSCLC due to lack of clinical benefit, erlotinib hydrochloride may be used in other combinations based on the treatment protocol and patient's condition.

  7. Adjuvant Therapy Option: It may be applied as targeted adjuvant treatment for resected early‑stage EGFR‑mutant NSCLC to lower postoperative recurrence risk.

  8. Symptom Control for Advanced Malignant Tumors: Erlotinib hydrochloride helps relieve tumor‑related clinical symptoms such as cough, chest pain and dyspnea in advanced EGFR‑driven NSCLC patients, improving patients’ quality of life.

  FAQ  

1.DO YOU ACCEPT SAMPLE ORDER?
Yes. We support sample orders for your trial production. And after the sample approved, we can negotiate for commercial order.


2.HOW TO CONFIRM THE PRODUCT QUALITY BEFORE PLACING ORDERS?
We support free sample, you only need to pay the shipping cost or arrange a courier to us and take the samples. We can also provide customized materials according to your specification demands.


3.WHAT'S YOUR MOQ?
Our don’t have MOQ restriction, even 1kg is available from us.

4. IS THERE A DISCOUNT?
Depends on the quantity you take. Different quantity has different discount.

 

  Our Advantage  

Almost 20 Years Experience
Our products are sold worldwide, like Europe, North&South America, Asia and pacific area as well as Africa, we are aiming to establish long term cooperation with our clients.

One-Stop Service
Committed to supplying healthy raw materials to the world, providing the highest quality raw materials for the world's health products, sports supplements, cosmetics, pharmaceuticals and other fields. Customized product is also available from us.
 

7 DAYS 24 HOURS service

In time and clear response to customers questions. 100% guaranteed aftersales service, we are happy to provide guidance or solutions during your consumption.

Quality Assurance
Dedicated to provide high-quality materials for customers  with reasonable price.

 
Recommend Products

Send Message